MedTrace Logo

Perennial Allergic Rhinitis Study In Pediatric Subjects

NCT00108914 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 558

Last updated 2017-01-19

No results posted yet for this study

Summary

The purpose of this study is to determine if the investigational drug is effective and safe in children with perennial allergic rhinitis.

Conditions

  • Rhinitis, Allergic, Perennial

Interventions

DRUG

GW685698X

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2005-11-30
Completion
2005-11-30

Countries

  • United States
  • Argentina
  • Chile
  • Finland
  • Italy
  • Mexico
  • Slovakia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00108914 on ClinicalTrials.gov